Osteogenic protein-1 regulates insulin-like growth Factor-I (IGF-I), IGF-II, and IGF-binding protein-5 (IGFBP-5) gene expression in fetal rat calvaria cells by different mechanisms

Journal of Cellular Physiology

Volumn 175, Issue 1, 1998, Pages 78-88

  Yeh, Lee Chuan C ^a   Adamo, Martin L ^a   Duan, Cunming ^b   Lee, John C ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; OSTEOGENIC PROTEIN 1; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN C;

ANIMAL CELL; ARTICLE; CALVARIA; CELL CULTURE; CELL DIVISION; CONTROLLED STUDY; GENE EXPRESSION; IN VITRO STUDY; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; RAT; RNA ANALYSIS;

ANIMALS; BONE MORPHOGENETIC PROTEINS; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 5; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; RNA PRECURSORS; RNA, MESSENGER; SKULL; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA;

ANIMALIA; RODENTIA; TRIXIS;

EID: 0031937094     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4652(199804)175:1<78::AID-JCP9>3.0.CO;2-9     Document Type: Article

References (66)

1. Adamo, M.L. (1995) Regulation of insulin-like growth factor-I gene expression: Implications for normal and pathological growth. Diabetes Rev., 3:2-27.
2. Andrews, P.W., Damjanov, I., Berends, J., Kumpf, S., Zappavigna, V., Mavilio, F., and Sampath, T.K. (1994) Inhibition of proliferation and induction of differentiation of pluripotent human embryonal carcinoma cells by OP-1 (BMP-7). Lab. Invest., 71:243-251.
3. Aronow, M.A., Gerstenfeld, L.C., Owen, T.A., Tassinari, M.S., Stein, G.S., and Lian, J.B. (1990) Factors that promote progressive development of the osteoblast phenotype in cultured fetal rat calvarial cells. J. Cell. Physiol., 143:213-221.
4. Asahina, I., Sampath, T.K., Nishimura, I., and Hauschka, P.V. (1993) Human osteogenic protein-1 induces both chondroblastic and osteoblastic differentiation of osteoprogenitor cells derived from newborn rat calvaria. J. Cell Biol., 123:921-933.
5. Bichell, D.P., Rotwein, P., and McCarthy, T.L. (1993) Prostaglandin E2 rapidly stimulates insulin-like growth factor I gene expression in primary rat osteoblast cultures: Evidence for transcriptional control. Endocrinology, 133:1020-1028.
6. Canalis, E., and Gabbitas, B. (1994) Bone morphogenetic protein-2 increases insulin-like growth factor I and II synthesis in bone cell cultures. J. Bone Miner. Res., 9:1999-2005.
7. Canalis, E., and Gabbitas, B. (1995) Skeletal growth factors regulate the synthesis of insulin-like growth factor-binding protein-5 in bone cell structures. J. Biol. Chem., 270:10771-10776.
8. Canalis, E., McCarthy, T.L., and Centrella, M. (1988a) Growth factors and the regulation of bone remodeling. J. Clin. Invest., 81:277-281.
9. Canalis, E., McCarthy, T.L., and Centrella, M. (1988b) Isolation and characterization of insulin-like growth factor 1 (somatomedin-C) from cultures of fetal rat calvariae. Endocrinology, 122:22-27.
10. Canalis, E., Pash, J., and Varghese, S. (1993) Skeletal growth factor. Crit. Rev. Eukaryot. Gene Expr., 3:155-166.
11. Centrella, M., McCarthy, T.L., and Canalis, E. (1991a) Glucocorticoid regulation of transforming growth factor β1 activity and binding in osteoblast-enriched cultures from fetal rat bone. Mol. Cell. Biol., 11:4490-4496.
12. Centrella, M., McCarthy, T.L., Kusmik, W.F., and Canalis, E. (1991b) Relative binding and biochemical effects of heterodimeric and homodimeric isoforms of platelet-derived growth factor in osteoblast-enriched cultures of fetal rat bone. J. Cell. Physiol., 147:420-426.
13. Chen, C., and Okayama, H. (1987) High efficiency transformation of mammalian cell by plasmid DNA. Mol. Cell. Biol., 2:607-616.
14. Chen, P., Vukicevic, S., Sampath, T.K., and Luyten, F.P. (1995) Osteogenic protein-1 promotes growth and maturation of chick sternal chondrocytes in serum-free cultures. J. Cell Sci., 108:105-114.
15. Chen, T.L., Chang, L.L., DiGregorio, D.A., Perlman, A.J., and Huang, Y.F. (1993) Growth factor modulation of insulin-like growth factor-binding proteins in rat osteoblast-like cells. Endocrinology, 733:1382-1389.
16. Cook, S.D., and Rueger, D.C. (1996) Osteogenic protein-1. Biology and applications. Clin. Orthop. Rel. Res., 324:29-38.
17. Cook, S.D., Baffes, G.C., Wolfe, M.W., Sampath, T.K., and Rueger, D.C. (1994a) Recombinant human bone morphogenetic protein-7 induces healing in a canine long-bone segmental defect model. Clin. Orthop. Rel. Res., 301:302-312.
18. Cook, S.D., Baffes, G.C., Wolfe, M.W., Sampath, T.K., Rueger, D.C., and Whitecloud, T.S. (1994b) The effect of recombinant human osteogenic protein-1 on healing of large segmental bone defects. J. Bone Joint Surg. [Am]., 76:827-838.
19. Cook, S.D., Wolfe, M.W., Salkeld, S.L., and Rueger, D.C. (1995) Recombinant human osteogenic protein-1 (rhOP-1) heals segmental defects in nonhuman primates. J. Bone Joint Surg., 77A:734-750.
20. DeChiara, T.M., Efstratiadis, A., and Robertson, E.J. ( 1990) A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature, 345:78-80.
21. Delany, A.M., and Canalis, E. (1995) Transcriptional repression of insulin-like growth factor-I by glucocorticoids in rat bone cells. Endocrinology, 136:4776-4781.
22. Dieudonne, S.C., Semeins, C.M., Goei, S.W., Vukicevic, S., Nulend, J.K., Sampath, T.K., Helder, M., and Burder, E.H. (1994) Opposite effects of osteogenic protein and transforming growth factor beta on chondrogenesis in cultured long bone rudiments. J. Bone Miner. Res., 9:771-780.
23. Dong, Y., and Canalis, E. (1995) Insulin-like growth factor (IGF) and retinoic acid induce the synthesis of IGF-binding protein 5 in rat osteoblastic cells. Endocrinology, 136:2000-2006.
24. Duan, C., and Clemmons, D.R. (1995) Transcription factor AP-2 regulates human insulin-like growth factor binding protein-5 gene expression. J. Biol. Chem., 270:24844-24851.
25. Ernst, M., and Rodan, G.A. (1991) Estradiol regulation of insulin-like growth factor I expression in osteoblastic cells: Evidence for transcriptional control. Mol. Endocrinol., 5:1081-1089.
26. Flechtenmacher, J., Huch, K., Thonar, E.J.M.A., Mollenhauer, J.A., Davies, S.R., Schmid, T.M., Puhl, W., Sampath, T.K., Aydelotte, M.B., and Kuettner, K.E. (1996) Recombinant human osteogenic protein 1 is a potent stimulator of the synthesis of cartilage proteoglycans and collagens by human articular chondrocytes. Arthritis Rheum., 39:1896-1904.
27. Foyt, H.L., LeRoith, D., and Roberts, C.T., Jr. (1991) Differential association of insulin-like growth factor I mRNA variants with polysomes in vivo. J. Biol. Chem., 266:7300-7305.
28. Frolik, C.A., Ellis, L.F., and Williams, D.C. (1988) Isolation and characterization of insulin-like growth factor II from human bone. Biochem. Biophys. Res. Commun., 151:1011-1018.
29. Gabbitas, B., and Canalis, E. (1995) Bone morphogenetic protein-2 inhibits the synthesis of insulin-like growth factor-binding protein-5 in bone cell cultures. Endocrinology, 136:2397-2403.
30. Gabbitas, B., and Canalis, E. (1996) Retinoic acid stimulates the transcription of insulin-like growth factor binding protein-6 in skeletal cells. J. Cell. Physiol., 169:15-22.
31. Gabbitas, B., Pash, J., and Canalis, E. (1994) Regulation of insulin-like growth factor-II synthesis in bone cell cultures by skeletal growth factors. Endocrinology, 135:284-289.
32. Greenberg, M.E. and Bender, T.P. (1997) Identification of newly transcribed RNA. In: Current Protocols in Molecular Biology. Ausubel, F.M., Brent, R., Kingston, R.E., Moore, D.D., Seidman, J.G., Smith, J.A., and Struhl, K. eds. pp. 4.10.1-4.10.11. John Wiley & Sons, New York.
33. Hassager, C., Fitzpatrick, L.A., Spencer, E.M., Riggs, B.L., and Conover, C.A. (1992) Basal and regulated secretion of insulin-like growth factor binding proteins in osteoblast-like cells is cell line specific. J. Clin. Endocrinol. Metab., 75:228-233.
34. Hepler, J.E., Van Wyk, J.J., and Lund, P.K. (1990) Different half-lives of insulin-like growth factor I mRNAs that differ in length of 3′ untranslated sequence. Endocrinology, 127:1550-1552.
35. Hock, J.M., Centrella, M., and Canalis, E. (1988) IGF-I has independent effects on bone matrix formation and cell replication. Endocrinology, 122:254-260.
36. Jones, J.I., and Clemmons, D.R. (1995) IGFs and their binding proteins: Biological actions. Endocr. Rev., 16:3-34.
37. Kanzaki, S., Baxter, R.C., Knutsen, R., Baylink, D.J., and Mohan, S. (1995) Evidence that human bone cells in culture secrete insulin-like growth factor (IGF)-II and IGF binding protein-3 but not acid-labile subunit both under basal and regulated conditions. J. Bone Miner. Res., 10:854-858.
38. Kitten, A.M., Lee, J.C., and Olson, M.S. (1995) Osteogenic protein-1 enhances phenotypic expression in ROS 17/2.8 cells. Am. J. Physiol., 269 (Endocrinol. Metab. 32):E918-E926.
39. Knutsen, R., Wergedal, J.E., Sampath, T.K., Baylink, D.J., and Mohan, S. (1993) Osteogenic protein-1 stimulates proliferation and differentiation of human bone cells in vitro. Biochem. Biophys. Res. Commun., 194:1352-1358.
40. Knutsen, R., Honda, Y., Strong, D.D., Sampath, T.K., Baylink, D.J., and Mohan, S. (1995) Regulation of insulin-like growth factor system components by osteogenic protein-1 in human bone cells. Endocrinology, 136:857-865.
41. LaTour, D., Mohan, S., Linkhart, T.A., Baylink, D.J., and Strong, D.D. (1990) Inhibitory insulin-like growth factor binding protein, cloning, complete sequence, and physiological regulation. Mol. Endocrinol., 4:1806-1814.
42. Li, I.W.S., Cheifetz, S., McCulloch, C.A.G., Sampath, T.K., and Sodek, J. (1996) Effects of osteogenic protein-1 (OP-1, BMP-7) on bone matrix protein expression by fetal rat calvarial cells are differentiation state specific. J. Cell. Physiol., 169:115-125.
43. Lipson, K.E., and Baserga, R. (1989) Transcriptional activity of the human thymidine kinase gene determined by a method using the polymerase chain reaction and an intron-specific probe. Proc. Natl. Acad. Sci. USA, 86:9774-9777.
44. Lyons, K.M., Hogan, B.L.M., and Robertson, E.J. (1995) Colocalization of BMP-7 and BMP-2 RNAs suggests that these factors cooperatively mediate tissue interactions during murine development. Mech. Dev., 50:71-83.
45. Maliakal, J.C., Asahina, I., Hauschka, P.V., and Sampath, T.K. (1994) OP-1 (BMP-7) inhibits cell proliferation and stimulates the expression of markers characteristic of osteoblast phenotype in rat osteosarcoma (17/2.8) cells. Growth Factors, 11:227-234.
46. McCarthy, T.L., Centrella, M., and Canalis, E. (1988) Further biochemical and molecular characterization of primary rat parietal bone cell cultures. J. Bone Miner. Res., 3:401-408.
47. McCarthy, T.L., Casinghino, S., Centrella, M., and Canalis, E. (1994) Complex pattern of insulin-like growth factor binding protein expression in primary rat osteoblast enriched cultures: Regulation by prostaglandin E2, growth hormone, and the insulin-like growth factors. J. Cell. Physiol., 160:163-175.
48. McCarthy, T.L., Thomas, M.J., Centrella, M., and Rotwein, P. (1995) Regulation of insulin-like growth factor I transcription by cyclic adenosine 3′,5′-monophosphate (cAMP) in fetal rat bone cells through an element within exon 1: Protein kinase A-dependent control without a consensus AMP response element. Endocrinology, 136:3901-3908.
49. Mohan, S., and Baylink, D.J. (1991a) Bone growth factors. Clin. Orthop. Rel. Res., 263:30-48.
50. Mohan, S., and Baylink, D.J. (1991b) The role of IGF-II in the coupling of bone formation to resorption. In: Modern Concepts of Insulin-Like Growth Factors. E.M. Spencer, ed. Elsevier, New York, pp. 169-184.
51. Mohan, S., Jennings, J.C., Linkhart, T.A., and Baylink, D.J. (1988) Primary structure of human skeletal growth factor: Homology with human insulin-like growth factor II. Biochim. Biophys. Acta, 966:44-45.
52. Okazaki, R., Riggs, B.L., and Conover, C.A. (1994) Glucocorticoid regulation of insulin-like growth factor-binding protein expression in normal human osteoblast-like cells. Endocrinology, 134:126-132.
53. Ozkaynak, E., Rueger, D.C., Drier, E.A., Corbett, C., Ridge, R.J., Sampath, T.K., and Oppermann, H. (1990) OP-1 cDNA encodes an osteogenic protein in the TGF-β family. EMBO J., 9:2085-2093.
54. Pash, J.M., and Canalis, E. (1996) Transcriptional regulation of insulin-like growth factor-binding protein-5 by prostaglandin E2 in osteoblast cells. Endocrinology, 137:2375-2382.
55. Pash, J.M., Delany, A.M., Adamo, M.L., Roberts, C.T., Jr., LeRoith, D., and Canalis, E. (1995) Regulation of insulin-like growth factor I transcription by prostaglandin E2 in osteoblast cells. Endocrinology, 136:33-38.
56. Sampath, T.K., and Rueger, D.C. (1994) Structure, function, and orthopaedic applications of osteogenic protein (OP-1). Complications Orthop., Winter, 101-107.
57. Sampath, T.K., Coughlin, J.E., Whetstone, R.M., Banach, D., Corbett, C., Ridge, R.J., Ozkaynak, E., Oppermann, H., and Rueger, D.C. (1990) Bovine osteogenic protein is composed of dimers of OP-1 and BMP-2A, two members of the transforming growth factor-β superfamily. J. Biol. Chem., 265:13198-13205.
58. Sampath, T.K., Maliakal, J.C., Hauschka, P.V., Jones, W.K., Sasak H., Tucker, R.F., White, K.H., Coughlin, J.E., Tucker, M.M., Pang, R.H.L., Corbett, C., Ozkaynak, E., Oppermann, H., and Rueger, D.C. (1992) Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro. J. Biol. Chem., 267:20352-20362.
59. Sodek, J., Chen, J., Nagata, T., Kasugai, S., Todescan, R., Jr., Li, I.W., and Kim, R.H. (1995) Regulation of osteopontin expression in osteoblasts. Ann. N.Y. Acad. Sci., 760:223-241.
60. Srinivasan, N., Knutsen, R., Baylink, D.J., Sampath, T.K., and Mohan, S. (1995) Evidence that TGF-β and BMP-7 increase insulin-like growth factor binding protein (IGFBP) -3 production via different protein kinase-C-dependent signal transduction pathways in human bone cells. J. Bone Miner. Res., 70(suppl 1):S310.
61. Thomas, M.J., Umayahara, Y., Shu, H., Centrella, M., Rotwein, P., and McCarthy, T.L. (1996) Identification of the cAMP response element that controls transcriptional activation of the insulin-like growth factor-I gene by prostaglandin E2 in osteoblasts. J. Biol. Chem., 271:21835-21841.
62. Wang, X., Yang, Y., and Adamo, M.L. (1997) Characterization of the rat IGF-I gene promoters and identification of a minimal exon 2 promoter. Endocrinology, 138:1528-1536.
63. Ward, A., Bates, P., Fisher, R., Richardson, L., and Graham, C.F. (1994) Disproportionate growth in mice with Igf-2 transgenes. Proc. Natl. Acad. Sci. USA 91:10365-10369.
64. Wergedal, J.E., Mohan, S., Lundy, M., and Baylink, D.J. (1990) Skeletal growth factor and other growth factors known to be present in bone matrix stimulate proliferation protein synthesis in human bone cells. J. Bone Miner. Res., 5:179-186.
65. Wozney, J.M., Rosen, V., Celeste, A.J., Mitsock, L.M., Whitters, M.J., Kriz, R.W., Hewick, R.M., and Wang, E.A. (1988) Novel regulators of bone formation: Molecular clones and activities. Science, 242:1528-1534.
66. Yeh, L.-C.C., Adamo, M.L., Kitten, A.M., Olson, M.S., and Lee, J.C. (1996) Osteogenic protein-1-mediated IGF gene expression in primary cultures of rat osteoblastic cells. Endocrinology, 137:1921-1931.